Matt Scranton
About Matt Scranton
Matt Scranton is a Senior Clinical Trial Administrator at Lyndra Therapeutics, with a background in clinical research and military service. He holds a Master of Science in Epidemiology from the University of Massachusetts Amherst and has extensive experience in healthcare and research roles.
Work at Lyndra Therapeutics
Matt Scranton has been employed at Lyndra Therapeutics since 2020, serving as a Senior Clinical Trial Administrator. In this role, he is responsible for overseeing clinical trials and ensuring compliance with regulatory standards. His work contributes to the development of innovative therapies aimed at improving patient outcomes. Lyndra Therapeutics is located in Watertown, Massachusetts, where Scranton has been instrumental in managing trial logistics and data collection.
Previous Experience at Dana-Farber Cancer Institute
Before joining Lyndra Therapeutics, Matt Scranton worked at the Dana-Farber Cancer Institute as a Clinical Research Coordinator from 2018 to 2020. During his two-year tenure, he coordinated various clinical research projects, focusing on cancer treatment and patient care. His experience at Dana-Farber provided him with valuable insights into clinical research methodologies and patient interactions.
Education and Expertise
Matt Scranton is currently pursuing a Master of Science in Epidemiology at the University of Massachusetts Amherst, a program he has been part of since 2021. He previously earned a Bachelor of Science in Pre-Medicine/Pre-Medical Studies from the University of Massachusetts Boston, completing his degree in 2018. His academic background equips him with a solid foundation in medical research and public health.
Background in Military Service
Matt Scranton served in the US Navy Reserve as a Hospital Corpsman from 2013 to 2020. Over his seven years of service, he gained extensive experience in medical care and emergency response. This background has contributed to his skills in clinical settings and patient management.
Research Interests
Matt Scranton has specific research interests in Genetic Epidemiology, Clinical Epidemiology, Health Inequities, and Cancer. His focus on these areas reflects his commitment to understanding and addressing public health challenges. His academic and professional experiences align with his research pursuits, enhancing his contributions to the field.